Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

NCT01850966 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT01850966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis
Lead sponsor
Eisai Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
September 12, 2012
Completion date
April 13, 2014
Enrollment
2,747 (actual)
Sites
453

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis